Data / Form D filings / RedLeaf Biologics, Inc.
RedLeaf Biologics, Inc.: Form D filings
RedLeaf Biologics, Inc., a biotechnology company in Lexington, KY, filed 4 Form D notices with the SEC between 2016 and 2019. The latest, on November 7, 2019, reports $750,000 sold of a $750,000 offering to 2 investors.
Find out what RedLeaf Biologics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 145 GRAHAM AVE., ASTECC BUILDING - SUITE A159, Lexington, KY, 40506
- Phone
- (205) 910-0641
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2015
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 504
- SEC identifier (CIK)
- 1677182
The full lists. Form D filings in Kentucky: 216 rows, $10.80, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 7, 2019 | New notice | $750,000 | $750,000 | $0 | 2 | Sep 6, 2019 | sec.gov |
| Dec 19, 2016 | Amendment | $166,605 | $5 | $166,600 | 1 | Aug 11, 2016 | sec.gov |
| Dec 5, 2016 | New notice | $24,000 | $5,000 | $19,000 | 1 | Aug 11, 2016 | sec.gov |
| Jun 16, 2016 | New notice | $278,000 | $250,000 | $28,000 | 8 | Jun 24, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Seth DeBolt | Executive Officer, Director | |
| Chris Somerville | Director | |
| William Baker | Director | |
| Heather Youngs | Director | |
| Jordan Wood | Executive Officer |
Every Form D from the week of Nov 4, 2019 · All recent filings in Kentucky · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what RedLeaf Biologics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.